Skip to main content

Table 2 Cost of medicine, in dollars, on lawsuits involving medication in the period between 2016 and 2018

From: Profile of judicialization in access to antineoplastic drugs and their costs: a cross-sectional, descriptive study based on a set of all lawsuits filed between 2016 and 2018 in a state in the Northeast Region of Brazil

Characteristics

General

(n = 2,947)

Antineoplastic Drugs

(n = 1,182)

Non-Antineoplastic Drugs

(n = 1,671

P-value

Total expense on lawsuit

1,734.94

(232 – 7,792)

7,508.83

(2,402 – 15,571)

585.36

(86 – 2,635)

 < 0.001

Unit price of medication

 In dollars

17.99

(1.94 – 142.23)

64.91

(14.60 – 359.40)

4.09

(0.53 – 65.87)

 < 0.001

 Sex

p-valuea = 0.019

p-valuea = 0.131

p-valuea = 0.007

 

  Male

2,120.33

(245.16 – 8,761.78)

8,654.14

(2,875,.79 –15,578.96)

468.40

(54,11 – 2,546.65)

 < 0.001

  Female

1,405.02

(220.92 – 6,621.09)

6,492.30

(1,928.70 –15,410.61)

618.53

(115.21 – 2,956.67)

 < 0.001

 Origin

p-valuea < 0.001

p-valuea = 0.071

p-valuea = 0.251

 

  Private

993.83

(168.74 – 4,948.80)

7,785.41

(3,244.89 –15,949.03)

595.06

(116.96 – 1,646.50)

 < 0.001

  SUS

2,482.45

(224.41 – 9,374.88)

7,964.82

(2,875.79 –15,410.61)

589.43

(81.66 – 3,556.58)

 < 0.001

  Philanthropic

2,128.67

(315.25 – 8,633.58)

6,475.23

(1,752.20 –14,170.84)

448.04

(52.37 – 2,634.51)

 < 0.001

Number of medications

 One

2,903 (98.5%)

1,255 (99.7%)

1,719 (97.8%)

 < 0.001

 Two

33 (1.1%)

0 (0%)

31 (1.8%)

 

 Three or more

11 (0.4%)

4 (0.3%)

7 (0.4%)

 

Maximum duration of treatment

 Months

6 (3 – 9)

5 (3 – 9)

6 (3 – 9)

 < 0.001

  1. N.B.: Sums in Brazilian reais were converted into US dollars using the commercial exchange rate for selling: real (R$)/US dollar (US$), mean value for 2020 (R$5,1558). Source: IPEA Retrieved from http://www.ipeadata.gov.br/ExibeSerie.aspx?serid=31924 August 2021